| Feb 23, 2026 |
Feb 23, 2026 |
Patience David
|
CFO |
Buy |
78.8
|
+3,657
|
1.38%
|
✗
|
$15K |
| Feb 23, 2026 |
Feb 23, 2026 |
Gordon Gary B.
|
Director |
Buy |
91.3
|
+9,756
|
100.00%
|
✗
|
$40K |
| Feb 23, 2026 |
Feb 23, 2026 |
Valle William
|
Director |
Buy |
95.0
|
+30,487
|
100.00%
|
✗
|
$125K |
| Feb 23, 2026 |
Feb 23, 2026 |
Szela Mary T
|
CEO |
Buy |
87.5
|
+30,487
|
4.10%
|
✗
|
$125K |
| Feb 23, 2026 |
Feb 23, 2026 |
Stansky Michael P
|
Director |
Buy |
100.0
|
+361,098
|
57.71%
|
✗
|
$1.5M |
| Feb 4, 2026 |
Feb 11, 2026 |
Stansky Michael P
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 11, 2026 |
Stansky Michael P
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 24, 2025 |
Nov 25, 2025 |
Cox Bryan F.
|
Chief of Research |
Neutral |
90.0
|
+40,000
|
31.60%
|
✗
|
- |
| Nov 24, 2025 |
Nov 25, 2025 |
Devlin Jodi
|
Chief of Clinical Operations |
Neutral |
90.0
|
+50,000
|
98.87%
|
✗
|
- |
| Feb 13, 2024 |
Nov 25, 2025 |
Szela Mary T
|
CEO |
Neutral |
90.0
|
+550,000
|
285.27%
|
✗
|
- |
| Nov 24, 2025 |
Nov 25, 2025 |
Stevens Jennifer
|
Chief Regulatory Officer |
Neutral |
90.0
|
+50,000
|
64.40%
|
✗
|
- |
| Nov 24, 2025 |
Nov 25, 2025 |
Marshak Richard
|
Chief Commercial Officer |
Neutral |
90.0
|
+60,000
|
111.41%
|
✗
|
- |
| Nov 24, 2025 |
Nov 25, 2025 |
Patience David
|
CFO |
Neutral |
90.0
|
+65,000
|
32.50%
|
✗
|
- |
| Sep 12, 2024 |
Sep 13, 2024 |
Szela Mary T
|
CEO |
Buy |
87.5
|
+14,815
|
4.01%
|
✗
|
$75.4K |
| Sep 10, 2024 |
Sep 12, 2024 |
Szela Mary T
|
CEO |
Buy |
78.8
|
+5,000
|
1.37%
|
✗
|
$24.9K |
| Aug 28, 2024 |
Sep 10, 2024 |
Martin George Kelly
|
Director |
Sell |
52.5
|
-9
|
0.00%
|
✗
|
$49.5 |
| Aug 13, 2024 |
Aug 21, 2024 |
Wahlstrom Mats
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 13, 2024 |
Aug 21, 2024 |
Hyveled Liselotte
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 13, 2024 |
Aug 21, 2024 |
HICKS KERRY R
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 13, 2024 |
Aug 21, 2024 |
Martin George Kelly
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 13, 2024 |
Aug 21, 2024 |
MATLIN DAVID J
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 13, 2024 |
Aug 21, 2024 |
Desai Arjun JJ
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 13, 2024 |
Aug 21, 2024 |
Singhal Anil K.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 13, 2024 |
Aug 21, 2024 |
VON ESCHENBACH ANDREW C.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 1, 2024 |
Jul 2, 2024 |
Desai Arjun JJ
|
Director |
Neutral |
90.0
|
+74,000
|
36.43%
|
✗
|
- |
| Jun 3, 2024 |
Jun 5, 2024 |
VON ESCHENBACH ANDREW C.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
May 21, 2024 |
Martin George Kelly
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 6, 2024 |
May 7, 2024 |
Hyveled Liselotte
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
May 7, 2024 |
Hyveled Liselotte
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 13, 2024 |
Feb 14, 2024 |
Szela Mary T
|
CEO |
Neutral |
90.0
|
+84,899
|
30.33%
|
✗
|
- |
| Feb 12, 2024 |
Feb 14, 2024 |
Marshak Richard
|
SR.VP, CORP. DEV. & STRATEGY |
Neutral |
90.0
|
+14,752
|
118.03%
|
✗
|
- |
| Feb 12, 2024 |
Feb 14, 2024 |
Cox Bryan F.
|
CHIEF SCIENTIFIC & MANUFACT. |
Neutral |
90.0
|
+14,752
|
20.50%
|
✗
|
- |
| Feb 12, 2024 |
Feb 14, 2024 |
Stevens Jennifer
|
CHIEF REGULATORY OFFICER |
Neutral |
90.0
|
+14,752
|
81.81%
|
✗
|
- |
| Feb 12, 2024 |
Feb 14, 2024 |
Devlin Jodi
|
President |
Neutral |
90.0
|
+17,500
|
100.00%
|
✗
|
- |
| Feb 12, 2024 |
Feb 14, 2024 |
Murphy Sean
|
CFO |
Neutral |
85.0
|
+34,144
|
6.30%
|
✗
|
- |
| Feb 12, 2024 |
Feb 14, 2024 |
Katz Steven C
|
CHIEF MEDICAL OFFICER |
Neutral |
90.0
|
+34,144
|
99.13%
|
✗
|
- |
| Jan 24, 2024 |
Jan 25, 2024 |
Murphy Sean
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 24, 2024 |
Jan 25, 2024 |
Marshak Richard
|
SR.VP, CORP. DEV. & STRATEGY |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 30, 2023 |
Aug 31, 2023 |
Devlin Jodi
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 31, 2023 |
Devlin Jodi
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 14, 2023 |
Aug 15, 2023 |
Szela Mary T
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 15, 2023 |
Szela Mary T
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 11, 2023 |
Aug 14, 2023 |
Stevens Jennifer
|
Chief Regulatory Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 14, 2023 |
Stevens Jennifer
|
Chief Regulatory Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 11, 2023 |
Aug 14, 2023 |
Murphy Sean
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 14, 2023 |
Murphy Sean
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 11, 2023 |
Aug 14, 2023 |
Marshak Richard
|
Sr.VP, Corp. Dev. & Strategy |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 14, 2023 |
Marshak Richard
|
Sr.VP, Corp. Dev. & Strategy |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 11, 2023 |
Aug 14, 2023 |
Katz Steven C
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 14, 2023 |
Katz Steven C
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 11, 2023 |
Aug 14, 2023 |
Cox Bryan F.
|
Chief Scientific & Manufact. |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 14, 2023 |
Cox Bryan F.
|
Chief Scientific & Manufact. |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 14, 2023 |
Alecxih James
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 14, 2023 |
Frankenius Equity AB
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 10, 2023 |
Aug 14, 2023 |
Wahlstrom Mats
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 14, 2023 |
Wahlstrom Mats
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 10, 2023 |
Aug 14, 2023 |
VON ESCHENBACH ANDREW C.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 14, 2023 |
VON ESCHENBACH ANDREW C.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 10, 2023 |
Aug 14, 2023 |
Singhal Anil K.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 14, 2023 |
Singhal Anil K.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 10, 2023 |
Aug 14, 2023 |
MATLIN DAVID J
|
Director |
Neutral |
90.0
|
+931,904
|
100.00%
|
✗
|
- |
| Aug 10, 2023 |
Aug 14, 2023 |
Martin George Kelly
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 14, 2023 |
Martin George Kelly
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 10, 2023 |
Aug 14, 2023 |
HICKS KERRY R
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 14, 2023 |
HICKS KERRY R
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 10, 2023 |
Aug 14, 2023 |
Desai Arjun JJ
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 14, 2023 |
Desai Arjun JJ
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 26, 2023 |
Jun 27, 2023 |
MedTech Acquisition Sponsor LLC
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 12, 2023 |
Jun 14, 2023 |
Magnetar Financial LLC
|
10% Owner |
Sell |
17.5
|
-445,828
|
-71.55%
|
✗
|
$4.7M |
|
Dec 22, 2022 |
Magnetar Financial LLC
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
May 3, 2021 |
TREADWELL DAVID L
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
May 3, 2021 |
Aguero Manuel
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 22, 2021 |
Thaure Thierry B.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 22, 2020 |
Dec 28, 2020 |
MedTech Acquisition Sponsor LLC
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 22, 2020 |
Dec 28, 2020 |
MATLIN DAVID J
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 22, 2020 |
Dec 28, 2020 |
Dewey Christopher C
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Dec 17, 2020 |
MedTech Acquisition Sponsor LLC
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Dec 17, 2020 |
Karti Karim
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Dec 17, 2020 |
Weiss Robert H.
|
Chief Admin Officer and Sec. |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Dec 17, 2020 |
Ferre Maurice R
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Dec 17, 2020 |
Delevic Ivan
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Dec 17, 2020 |
Roche Martin William
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Dec 17, 2020 |
MATLIN DAVID J
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Dec 17, 2020 |
Dewey Christopher C
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |